Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

I had hope of AGN leading the pack for treatment Trials. We are still at the fore front but the Swiss hype and IND status will make AGN prove success as compared to theories.
Somewhat disappointed with our CROs, expected more from both. But we really dont know progress and first dosed patient news came out at the same time as other news dominated the field.
Canada could have been more supportive and the AGN/USFDA team should be pushing our story VERY harder here. What happened with 'orphan drug' or IND status?
The Swiss will still need to actually have pertinent new data re; snorting ED drugs for COVID (2B OS 2018 and PK debt).?. I am betting the AGN story will raise to the top through the Science and undeniable data. First to data may still happen. The need for verified COVID solutions are expanding as is the IPF/CC/ARDS recovery caseloads. Treatments will be long term, IMO...GLTA...